San Francisco's Montara Therapeutics secures $20 million in seed funding to advance epilepsy drug development and explore ...

A major Japanese labour union group said on Thursday its member unions had struck agreements for substantial wage hikes, ...

A major Japanese labour union group said on Thursday its member unions had struck agreements for hefty wage hikes with ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company’s cell ...

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potent ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

Novel Modes of Treatment and Drugs Spur the Demand in the Immuno-oncology Market: Fact Report ROCKVILLE, MD, UNITED STATES, March 13, ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

Affecting up to 10% of women of reproductive age, endometriosis is a painful condition caused by tissue normally found lining ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA ...